Foxo Revenue and Competitors
Estimated Revenue & Valuation
- Foxo's estimated annual revenue is currently $2.4M per year.
- Foxo's estimated revenue per employee is $162,000
Employee Data
- Foxo has 15 Employees.
- Foxo grew their employee count by -12% last year.
Foxo's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & CEO | Reveal Email/Phone |
2 | Quality Assurance and Development Manager | Reveal Email/Phone |
3 | Implementation Specialist | Reveal Email/Phone |
4 | Business Development Manager | Reveal Email/Phone |
Foxo Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $54.4M | 183 | 6% | N/A | N/A |
#2 | $18M | 74 | -4% | N/A | N/A |
#3 | $162.7M | 482 | 39% | N/A | N/A |
#4 | $42.8M | 144 | 8% | N/A | N/A |
#5 | $26.5M | 98 | 4% | N/A | N/A |
#6 | $33.2M | 123 | -2% | N/A | N/A |
#7 | $29.7M | 110 | 12% | N/A | N/A |
#8 | $15.5M | 66 | -21% | $29.7M | N/A |
#9 | $1645.8M | 4354 | 13% | N/A | N/A |
#10 | $43.7M | 147 | 18% | N/A | N/A |
What Is Foxo?
Foxo is on a mission to connect a fragmented health system. Our technical and clinical-led team enables us to engineer modern solutions to today's communication challenges. A rapidly growing user base of forward-thinking health care professionals rely on our technology every day.
keywords:N/AN/A
Total Funding
15
Number of Employees
$2.4M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Foxo News
The second company, FOXO Technologies Inc, develops technology related to actuarial modeling for life insurance policies.
NEOGEN Corporation and FOXO Technologies Inc have collaborated for an extensive epigenetic datasets research project examining the...
FOXOs are also implicated in protection against neurodegenerative conditions. In C. elegans, FOXO/DAF-16 (abnormal DAuer Formation-16) activity...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | -21% | N/A |
#2 | $1.3M | 15 | N/A | N/A |
#3 | $1.3M | 15 | -12% | N/A |
#4 | $3.8M | 15 | -35% | N/A |
#5 | $1.4M | 16 | -20% | N/A |